Exclusive: Third death revealed in China's popular but opaque trials
negativeNegative
AI Analysis
Summary
A patient with autoimmune disease died after receiving an experimental genetic medicine from Shanghai-based RiboX Therapeutics, marking the third death revealed in China's clinical trials for this experimental therapy.
Clinical Trial Data
Outcome Details
Patient death reported in experimental genetic medicine trial
Importance:8/10
Sentiment:
-0.95
adverse eventpatient deathgenetic medicineChinaclinical trial safetyregulatory oversight
Read the original article
Published by Endpoints News on August 18, 2026 2:25 PM